From: Effects of nicotinamide on follicular development and the quality of oocytes
Parameters | Group1 | Group2 | Group3 | P |
---|---|---|---|---|
n = 63 | n = 64 | n = 63 | ||
NAM (μg/L) | ||||
 Median | 33.61 | 43.88 | 59.38 |  |
 Range | 8.57–38.78 | 38.8–49.29 | 49.39–251.15 |  |
Age (years) | 32.29 ± 0.74 | 32.52 ± 0.75 | 31.67 ± 0.59 | 0.674 |
BMI (kg/m2) | 22.35 ± 0.41 | 22.86 ± 0.39 | 22.41 ± 0.46 | 0.649 |
AFC (n) | 15.32 ± 0.85 | 15.84 ± 1.05 | 14.71 ± 0.79 | 0.680 |
Basal LH (mIU/ml) | 4.76 ± 0.32 | 4.68 ± 0.43 | 4.46 ± 0.36 | 0.844 |
Basal FSH (mIU/ml) | 10.07 ± 0.78 | 8.23 ± 0.53 | 9.12 ± 0.55 | 0.120 |
AMH (ng/ml) | 3.11 ± 0.33 | 3.53 ± 0.42 | 3.07 ± 0.32 | 0.610 |
Basal E2 (pg/ml) | 37.37 ± 2.40 | 65.29 ± 8.40 | 42.05 ± 3.42 | 0.001* |
Gn duration (days) | 10.94 ± 0.42 | 10.75 ± 0.37 | 10.57 ± 0.34 | 0.793 |
Gn dose (IU) | 2386.91 ± 102.02 | 2350.78 ± 100.21 | 2338.89 ± 101.41 | 0.941 |
E2 on HCG day (pmol/L) | 3666.62 ± 393.25 | 4027.55 ± 582.21 | 4198.32 ± 407.98 | 0.719 |
Progesterone on HCG day (nmol/L) | 1.05 ± 0.10 | 1.05 ± 0.14 | 1.02 ± 0.07 | 0.975 |
LH on HCG day (IU/L) | 1.95 ± 0.34 | 1.81 ± 0.34 | 2.00 ± 0.38 | 0.923 |
FSH on HCG day (IU/L) | 16.10 ± 0.68 | 15.09 ± 0.54 | 15.44 ± 0.42 | 0.425 |
Oocytes retrieved (n) | 10.94 ± 1.16 | 10.33 ± 1.05 | 11.78 ± 1.00 | 0.633 |
Mature oocytes (n) | 7.46 ± 0.85 | 8.33 ± 0.91 | 8.79 ± 0.76 | 0.527 |
Oocyte maturation rate (%) | 67.90 ± 3.32 | 77.37 ± 2.99 | 78.56 ± 2.57 | 0.023* |
Fertilization rate (%) | 67.84 ± 3.33 | 76.84 ± 2.99 | 78.28 ± 2.57 | 0.030* |
Cleavage rate (%) | 92.82 ± 3.09 | 95.93 ± 2.28 | 97.61 ± 0.98 | 0.328 |
High-quality embryo rate (%) | 49.06 ± 4.17 | 51.86 ± 4.27 | 48.31 ± 3.58 | 0.805 |
Clinical pregnancy rate (%) | 47.84 ± 6.12 | 46.33 ± 6.03 | 53.19 ± 5.80 | 0.688 |